title: B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis.
abstract: The approach to treating autoimmune disorders is currently undergoing a significant change in focus. As therapies are developed that are more precise in targeting the pathogenesis for these diseases, patients experience significantly fewer side effects. At the same time, as more precise therapies are discovered, the etiologies of these diseases become further elucidated. It is now widely accepted that B-lymphocytes play a significant role in the pathogenesis of various autoimmune diseases, the extent of which continues to be the focus of ongoing research. Rheumatoid arthritis is one such disease process that has been the focus of various B-lymphocyte-directed therapeutic trials. In this paper we review the current research available on rituximab as treatment for rheumatoid arthritis. This review details results from four main studies, as well as others, which used rituximab in at least one of the arms in treatment of rheumatoid arthritis. The results are promising and will likely lead to longer term studies as well as a potential focus on B cell subsets.
authors.affiliation: Hematology and Oncology, Veterans Affairs, Northern California Health Care System, California, USA; Division of Hematology and Oncology, University of California, Davis School of Medicine, Sacramento, California, USA. joseph.tuscano@ucdmc.ucdavis.edu
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Tuscano
authors.forename: Jacob
authors.initials: J
authors.lastname: Sands
references.citation: Intern Med. 2007;46(16):1313-5
references.pmid: 17704614
references.citation: Ann N Y Acad Sci. 1995 Sep 29;764:440-9
references.pmid: 7486562
references.citation: J Clin Pharmacol. 2005 Jul;45(7):792-801
references.pmid: 15951469
references.citation: Ann Rheum Dis. 2008 Mar;67(3):402-8
references.pmid: 17644541
references.citation: N Engl J Med. 2004 Jun 17;350(25):2572-81
references.pmid: 15201414
references.citation: Clin Immunol. 2003 Jun;107(3):140-51
references.pmid: 12804527
references.citation: J Pediatr Hematol Oncol. 2003 Dec;25 Suppl 1:S57-61
references.pmid: 14668642
references.citation: J Exp Med. 1999 May 17;189(10):1639-48
references.pmid: 10330443
references.citation: Annu Rev Immunol. 2001;19:275-90
references.pmid: 11244038
references.citation: Blood. 2001 Aug 15;98(4):952-7
references.pmid: 11493438
references.citation: Arthritis Rheum. 2008 Oct;58(10):2993-9
references.pmid: 18821683
references.citation: Arthritis Res Ther. 2004;6(4):R303-8
references.pmid: 15225365
references.citation: J Rheumatol. 2005 Nov;32(11):2109-15
references.pmid: 16265687
references.citation: Neurology. 2003 Dec 23;61(12):1652-61
references.pmid: 14694025
references.citation: Nat Clin Pract Rheumatol. 2007 May;3(5):262-72
references.pmid: 17471245
references.citation: Haematologica. 2003 May;88(5):538-46
references.pmid: 12745273
references.citation: Blood. 2001 Apr 1;97(7):2171-2
references.pmid: 11264188
references.citation: J Allergy Clin Immunol. 2003 Apr;111(4):697-703
references.pmid: 12704346
references.citation: Br J Haematol. 2004 Apr;125(2):232-9
references.pmid: 15059147
references.citation: Arthritis Rheum. 2005 Aug;52(8):2506-12
references.pmid: 16052584
references.citation: N Engl J Med. 2003 Jun 19;348(25):2543-56
references.pmid: 12815141
references.citation: Arthritis Rheum. 2004 Apr;50(4):1051-65
references.pmid: 15077287
references.citation: Arthritis Rheum. 2004 May;50(5):1400-11
references.pmid: 15146409
references.citation: Arthritis Rheum. 2008 Dec;58(12):3657-64
references.pmid: 19035505
references.citation: Arthritis Rheum. 2003 Oct;48(10):2741-9
references.pmid: 14558078
references.citation: Semin Oncol. 2000 Dec;27(6 Suppl 12):17-24
references.pmid: 11225995
references.citation: Clin Ther. 2000 Jan;22(1):128-39
references.pmid: 10688396
references.citation: J Rheumatol. 2008 Jan;35(1):20-30
references.pmid: 18050385
references.citation: Med Care. 2005 Jan;43(1):79-87
references.pmid: 15626937
references.citation: N Engl J Med. 2002 Jan 24;346(4):235-42
references.pmid: 11807147
references.citation: Ann Intern Med. 2007 Jun 5;146(11):797-808
references.pmid: 17548411
references.citation: J Exp Med. 1994 Oct 1;180(4):1295-306
references.pmid: 7931063
references.citation: J Autoimmun. 1997 Feb;10(1):87-97
references.pmid: 9080303
references.citation: Arthritis Rheum. 2008 Jun;58(6):1566-75
references.pmid: 18512772
references.citation: Ann Rheum Dis. 2008 Jul;67(7):917-25
references.pmid: 17965121
references.citation: Arthritis Rheum. 2007 Mar;56(3):772-8
references.pmid: 17328049
references.citation: Science. 2001 Jan 19;291(5503):484-6
references.pmid: 11161202
references.citation: Arthritis Rheum. 2006 Sep;54(9):2793-806
references.pmid: 16947627
references.citation: Ann Rheum Dis. 2009 Feb;68(2):216-21
references.pmid: 18388156
references.citation: Arthritis Rheum. 2006 May;54(5):1390-400
references.pmid: 16649186
references.citation: N Engl J Med. 2001 Aug 2;345(5):340-50
references.pmid: 11484692
references.citation: J Clin Oncol. 1998 Aug;16(8):2825-33
references.pmid: 9704735
references.citation: Semin Oncol. 2000 Dec;27(6 Suppl 12):99-103
references.pmid: 11226008
references.citation: Rheumatology (Oxford). 2006 Dec;45(12):1505-13
references.pmid: 17062648
references.citation: J Clin Pharmacol. 2007 Sep;47(9):1119-28
references.pmid: 17766699